TDOC
TDOC
NYSE · Health Care

Teladoc Health Inc

$8.07
+0.48 (+6.32%)
As of Jun 21, 10:14 PM ET ·
Financial Highlights (FY 2026)
Revenue
2.85B
Net Income
-225,616,173
Gross Margin
69.5%
Profit Margin
-7.9%
Rev Growth
+1.7%
D/E Ratio
0.72
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 69.5% 69.5% 59.9% 59.9%
Operating Margin -10.4% -9.4% 14.5% 12.7%
Profit Margin -7.9% -7.5% 11.4% 11.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 2.85B 2.80B 196.92M 169.36M
Gross Profit 1.98B 1.95B 118.05M 101.52M
Operating Income -296,046,112 -262,039,241 28.47M 21.48M
Net Income -225,616,173 -199,699,602 22.43M 19.47M
Gross Margin 69.5% 69.5% 59.9% 59.9%
Operating Margin -10.4% -9.4% 14.5% 12.7%
Profit Margin -7.9% -7.5% 11.4% 11.5%
Rev Growth +1.7% +1.7% +7.3% +5.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 304.41M 304.41M 331.89M 372.61M
Total Equity 423.96M 423.96M 654.10M 617.48M
D/E Ratio 0.72 0.72 0.51 0.60
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 113.88M 106.40M 39.52M 34.03M
Free Cash Flow 11.14M 11.84M